You'll see psoriasis patients on a new biotech drug, Raptiva.

December 2003

You'll see psoriasis patients on a new biotech drug, Raptiva. It's an antibody that blocks T-cells responsible for psoriasis.

Raptiva (efalizumab) is similar to Amevive (alefacept)... but each drug blocks different cell receptors.

Raptiva is for moderate to severe plaque psoriasis.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

now recommend AGAINST keeping ipecac syrup in homes for accidental poisonings
Cardiology valsartan (Diovan) improves survival after a heart attack
Cardiology Reports on TV and in magazines are telling people that it's dangerous to STOP low-dose aspirin
Antidepressants New alternatives to Paxil are hitting the market
Antidepressants More stroke patients are now getting an antidepressant
Asthma Is it necessary to taper a short course of oral corticosteroids
Gastroenterology confused about the new OTC version of Prilosec
Psoriasis You'll see psoriasis patients on a new biotech drug, Raptiva.
Cholesterol foods labeled "heart healthy."
Cholesterol Which statins need to be taken in the evening
Neurology & Pain whether opiates cause hearing loss
More bipolar patients will be getting lithium
Risperdal Consta will be the first LONG-ACTING injectable ATYPICAL antipsychotic
Men's Health Cialis for erectile dysfunction
Women's Health new Rx estrogen cream, Estrasorb
Medication Errors eliminate dangerous abbreviations
Anticoagulants new oral anticoagulant called Exanta (ximelagatran, zye-mel-a-GAT-ran)